Atossa Therapeutics Inc. (ATOS)
NASDAQ: ATOS
· Real-Time Price · USD
0.78
-0.00 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
0.80
2.34%
After-hours: Aug 15, 2025, 07:37 PM EDT
Atossa Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 18K | 18K | 18K | 18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 16K | 16K | 17K | 27K | 26K | 25K | 23K | 11K | 10K | 9K | 8K | 7.74K | 11.95K | 15.74K | 23K | 21.27K | 15.05K | 9.26K |
Gross Profit | -16K | -16K | -17K | -9K | -8K | -7K | -5K | -11K | -10K | -9K | -8K | -7.74K | -11.95K | -15.74K | -23K | -21.27K | -15.05K | -9.26K |
Operating Income | -29.99M | -28.05M | -27.62M | -29.49M | -30.57M | -31.26M | -31.38M | -30.5M | -31.23M | -30.04M | -27.68M | -24.37M | -21.33M | -21.74M | -20.52M | -19.92M | -18.27M | -15.2M |
Interest Income | 3.2M | 3.63M | 4.05M | 4.45M | 4.72M | 4.63M | 4.34M | 3.98M | 2.9M | 1.93M | 1.08M | 206K | 12K | 1K | n/a | n/a | n/a | n/a |
Pretax Income | -28.72M | -26.34M | -25.5M | -26.91M | -25.91M | -29.69M | -30.09M | -29.83M | -31.61M | -28.45M | -26.96M | -24.3M | -21.49M | -21.85M | -20.61M | -23.26M | -21.55M | -18.42M |
Net Income | -28.72M | -26.34M | -25.5M | -26.91M | -25.91M | -29.69M | -29.27M | -28.36M | -29.95M | -26.87M | -26.23M | -24.22M | -21.6M | -21.89M | -20.61M | -23.26M | -21.55M | -18.42M |
Selling & General & Admin | 13.52M | 13.53M | 13.5M | 13.1M | 13.13M | 13.67M | 14.03M | 13.83M | 13.88M | 12.95M | 12.61M | 12.46M | 12.36M | 12.41M | 11.31M | 10.18M | 9.08M | 8.15M |
Research & Development | 16.47M | 14.53M | 14.12M | 16.37M | 17.42M | 17.57M | 17.33M | 16.67M | 17.36M | 17.09M | 15.08M | 11.92M | 8.96M | 9.33M | 9.21M | 9.74M | 9.19M | 7.05M |
Other Expenses | -4K | -4K | -4K | n/a | n/a | -30K | -63K | -63K | -63K | -33K | -39K | -42.63K | -81.18K | -116.66K | -85K | -67.57K | -11.28K | 53.87K |
Operating Expenses | 29.99M | 28.05M | 27.61M | 29.47M | 30.55M | 31.24M | 31.36M | 30.5M | 31.23M | 30.04M | 27.68M | 24.37M | 21.33M | 21.74M | 20.52M | 19.92M | 18.27M | 15.2M |
Interest Expense | n/a | n/a | n/a | 820K | 820K | 820K | 820K | n/a | n/a | n/a | n/a | 3.63K | 3.63K | 3.63K | 3.63K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -5K | -5K | -5K | -5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.99M | 28.05M | 27.62M | 29.49M | 30.57M | 31.26M | 31.38M | 30.5M | 31.23M | 30.04M | 27.68M | 24.37M | 21.33M | 21.74M | 20.52M | 19.92M | 18.27M | 15.2M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -820K | -1.47M | -1.66M | -1.58M | -725K | -74.37K | 158.18K | 116.66K | 85K | 81.37K | 25.08K | -40.07K |
Shares Outstanding (Basic) | 129.17M | 129.17M | 126.62M | 125.77M | 125.73M | 125.32M | 125.3M | 125.79M | 126.62M | 126.62M | 126.62M | 126.62M | 126.62M | 126.62M | 126.54M | 126.54M | 121.57M | 92.59M |
Shares Outstanding (Diluted) | 129.17M | 129.17M | 126.62M | 125.77M | 125.73M | 125.32M | 125.3M | 125.79M | 126.62M | 126.62M | 126.62M | 126.62M | 126.62M | 126.62M | 126.54M | 126.54M | 121.57M | 92.59M |
EPS (Basic) | -0.22 | -0.21 | -0.2 | -0.21 | -0.21 | -0.24 | -0.23 | -0.22 | -0.24 | -0.21 | -0.21 | -0.19 | -0.17 | -0.18 | -0.18 | -0.22 | -0.52 | -0.89 |
EPS (Diluted) | -0.22 | -0.21 | -0.2 | -0.21 | -0.21 | -0.24 | -0.23 | -0.22 | -0.24 | -0.21 | -0.21 | -0.19 | -0.17 | -0.18 | -0.18 | -0.22 | -0.52 | -0.89 |
EBITDA | -28.66M | -27.34M | -27.6M | -29.46M | -30.55M | -31.23M | -31.36M | -30.49M | -31.22M | -30.03M | -27.68M | -24.37M | -21.32M | -21.72M | -20.5M | -19.89M | -18.23M | -15.16M |
EBIT | -28.68M | -27.36M | -27.62M | -29.49M | -30.57M | -31.26M | -31.38M | -30.5M | -31.23M | -30.04M | -27.68M | -24.38M | -21.33M | -21.74M | -20.52M | -19.92M | -18.27M | -15.2M |
Depreciation & Amortization | 16K | 16K | 17K | 27K | 26K | 25K | 23K | 11K | 10K | 9K | 8K | 7.74K | 11.95K | 15.74K | 23K | 30.52K | 36.86K | 43.45K |